NeoPharm Co., Ltd. (092730) Price & Analysis

― Followers

092730 Stock Chart & Stats

₩18920.00

-₩380.00(-1.97%)

Jul 28, 2026

―

Day’s Range― - ―

52-Week Range₩15,590.00 - ₩22,650.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)49.12K

Market Cap

₩301.88B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)6.1

Beta0.13

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding16,027,988

10 Day Avg. Volume51,982

30 Day Avg. Volume49,122

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)3,005,873.72

Revenue Forecast (FY)₩10.00T>

092730 FAQ

What was NeoPharm Co., Ltd.’s price range in the past 12 months?

NeoPharm Co., Ltd. lowest stock price was ₩15590.00 and its highest was ₩22650.00 in the past 12 months.

What is NeoPharm Co., Ltd.’s market cap?

NeoPharm Co., Ltd.’s market cap is ₩301.88B.

When is NeoPharm Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were NeoPharm Co., Ltd.’s earnings last quarter?

NeoPharm Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩551.369 earnings per share for the quarter, beating the consensus estimate of N/A by ₩551.369.

Is NeoPharm Co., Ltd. overvalued?

According to Wall Street analysts NeoPharm Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does NeoPharm Co., Ltd. pay dividends?

NeoPharm Co., Ltd. does not currently pay dividends.

What is NeoPharm Co., Ltd.’s EPS estimate?

NeoPharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NeoPharm Co., Ltd. have?

NeoPharm Co., Ltd. has 16,027,988 shares outstanding.

What happened to NeoPharm Co., Ltd.’s price movement after its last earnings report?

NeoPharm Co., Ltd. reported an EPS of ₩551.369 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.251%.

Which hedge fund is a major shareholder of NeoPharm Co., Ltd.?

Currently, no hedge funds are holding shares in KR:092730

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NeoPharm Co., Ltd.

NeoPharm Co., Ltd. focuses on the invention, manufacturing, and distribution of various cosmetic, medical, and health-related goods. Their product line features advanced emulsified and specialized skincare solutions, particularly designed for individuals with sensitive or dry skin. Additionally, the company provides treatments for ailments like atopic dermatitis and psoriasis, alongside therapies aimed at mitigating the side effects of steroid use. Established on July 1, 2000, the firm's main office is situated in Daejeon, South Korea.